Isogenica and the Defence Science and Technology Laboratory develop antimicrobial peptide drugs with potential to treat MRSA

Written on 17 Feb, 2010 at 13:00 in Research | viewed 304 times | 0 Comments

Isogenica Ltd today announced that it has entered into an agreement with UK Ministry of Defence agency, the Defence Science and Technology Laboratory (Dstl). The agreement concerns the development of antimicrobial peptide drugs and follows a successful collaboration to identify... (Continue reading)